Fabry disease can be monitored through a variety of laboratory tests and assessments.1 It is important to remain aware that clinical vigilance and regular monitoring are essential, as an absence of symptoms at baseline or at follow-up assessment does not preclude subsequent development of organ complications.2
If your symptoms change or if they begin to occur more often or more severely, you should share this with your doctor.
Treatment and follow-up assessments to evaluate treatment responses should ideally be supervised by a physician experienced in the management of patients with Fabry disease, with input from sub-specialists who also have Fabry disease experience.2 This multidisciplinary clinical team may include a neurologist, nephrologist, cardiologist, medical geneticist, genetic counselor, psychologist, and nurse.2
It’s important to remember that your care team is there to help you so you can always ask as many questions as you need to.
Patients & Caregivers: In case of need to report an adverse drug reaction, please refer to your physician, asking him to fill in and submit the relevant case report to the concerned Health Authority, according to the Pharmacovigilance requirements in force in your Country. Nevertheless, please be kindly reminded that each patient can report any such cases directly to the national reporting system.
Healthcare Professionals: in case you want to report an adverse drug reaction you become aware of, please report it to your Health Authority according to the requirements set by the pharmacovigilance legislation.
You are now leaving Rethink Fabry. Please note that the site you are entering is not the property of nor managed by Chiesi.